Abstract:Adverse drug–drug interactions (DDIs) have become an increasingly serious problem in the medical and health system. Recently, the effective application of deep learning and biomedical knowledge graphs (KGs) have improved the DDI prediction performance of computational models. However, the problems of feature redundancy and KG noise also arise, bringing new challenges for researchers. To overcome these challenges, we proposed a Multi-Channel Feature Fusion model for multi-typed DDI prediction (MCFF-MTDDI). Specifically, we first extracted drug chemical structure features, drug pairs' extra label features, and KG features of drugs. Then, these different features were effectively fused by a multi-channel feature fusion module. Finally, multi-typed DDIs were predicted through the fully connected neural network. To our knowledge, we are the first to integrate the extra label information into KG-based multi-typed DDI prediction; besides, we innovatively proposed a novel KG feature learning method and a State Encoder to obtain target drug pairs' KG-based features which contained more abundant and more key drug-related KG information with less noise; furthermore, a Gated Recurrent Unit-based multi-channel feature fusion module was proposed in an innovative way to yield more comprehensive feature information about drug pairs, effectively alleviating the problem of feature redundancy. We experimented with four datasets in the multi-class and the multi-label prediction tasks to comprehensively evaluate the performance of MCFF-MTDDI for predicting interactions of known-known drugs, known-new drugs and new-new drugs. In addition, we further conducted ablation studies and case studies. All the results fully demonstrated the effectiveness of MCFF-MTDDI.

Multi-view feature representation and fusion for drug-drug interactions prediction

Multi-type feature fusion based on graph neural network for drug-drug interaction prediction

An effective framework for predicting drug–drug interactions based on molecular substructures and knowledge graph neural network

Prediction of multiple types of drug interactions based on multi-scale fusion and dual-view fusion

KGRLFF: Detecting Drug-Drug Interactions Based on Knowledge Graph Representation Learning and Feature Fusion

A multi-scale feature fusion model based on biological knowledge graph and transformer-encoder for drug-drug interaction prediction

Drug-drug Interaction Prediction with Graph Representation Learning

Hierarchical Multi-Relational Graph Representation Learning for Large-Scale Prediction of Drug-Drug Interactions

Attention-based Knowledge Graph Representation Learning for Predicting Drug-drug Interactions

MGDDI: A multi-scale graph neural networks for drug-drug interaction prediction

Comprehensive evaluation of deep and graph learning on drug-drug interactions prediction

Comprehensive evaluation of deep and graph learning on drug–drug interactions prediction

RGDA-DDI: Residual graph attention network and dual-attention based framework for drug-drug interaction prediction

KGNN: Knowledge Graph Neural Network for Drug-Drug Interaction Prediction

Multitype drug interaction prediction based on the deep fusion of drug features and topological relationships

MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction

Multi-View Substructure Learning for Drug-Drug Interaction Prediction

Predicting Drug-Drug Interactions Using Knowledge Graphs

Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning

A dual-modality complex-valued fusion method for predicting side effects of drug-drug interactions based on graph neural network.

Predicting Rich Drug-Drug Interactions via Biomedical Knowledge Graphs and Text Jointly Embedding